Improving the lives of our patients.
We work tirelessly to create life changing treatments that help our patients live better and fuller lives.Learn More
Research & Development
We invest in innovative research and development through our own development or partnerships to best address the unmet needs of patientsLearn More
We officially opened our new office and R&D lab space in Boston’s Seaport district.Learn More
Erik Lemay, our Head of Global External Manufacturing, recently spoke about the impact of manufacturing disruptions for cancer patients and the current landscape of the pharmaceutical supply chain.Learn More
Servier and Taiho Oncology Present Overall Survival Data for Trifluridine/Tipiracil (LONSURF®) In Combination With Bevacizumab in Patients With Refractory Metastatic Colorectal Cancer at 2023 ASCO Gastrointestinal Cancers SymposiumLearn More
Adobe Stock©Mat Hayward | Adobe Stock©REDPIXEL | Adobe Stock©Gorodenkoff | Adobe Stock©Monkey Business